Vilanterol Trifenatate

CAS 503070-58-4 9 current recordsSmall Molecule

Who holds supplier records for Vilanterol Trifenatate? 9 organisations hold a current record for Vilanterol Trifenatate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (4), Italy (1), Spain (1) and Malta (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Vilanterol Trifenatate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/vilanterol-trifenatate

Reading the evidence

  • 9 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (9)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Vilanterol Trifenatate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India4Italy1Spain1Malta1Country not recorded for 2
  • Cipla Limited
    Active DMF 39385 · latest filing Feb 2024
    India Company GMP cert on record
  • Farmabios S.p.A.
    Active DMF 44519 · latest filing Jul 2026
    Italy Company GMP cert on record
  • GLAXOSMITHKLINE LLC
    Active DMF 25906 · latest filing Jun 2012
  • INKE SA
    Active DMF 35498 · latest filing Mar 2023
    Spain
  • Lupin Limited
    Active DMF 36668 · latest filing Mar 2022
    India Company GMP cert on record
  • MSN Laboratories Private Limited
    Active DMF 34083 · latest filing Oct 2019
    India Company GMP cert on record
  • Neuland Laboratories Limited
    Active DMF 36450 · latest filing Jan 2022
    India
  • SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD
    Active DMF 44117 · latest filing May 2026
  • STERLING CHEMICAL MALTA LTD
    Active DMF 39842 · latest filing Apr 2024
    Malta Company GMP cert on record
Need Vilanterol Trifenatate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Vilanterol is a long-acting beta2-adrenergic agonist (LABA) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It works by relaxing muscles in the airways to improve breathing.

Chemical identity

IUPAC name
4-[(1R)-2-[6-[2-[(2,6-dichlorophenyl)methoxy]ethoxy]hexylamino]-1-hydroxyethyl]-2-(hydroxymethyl)phenol;2,2,2-triphenylacetic acid
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNC[C@@H](C2=CC(=C(C=C2)O)CO)O)Cl
InChIKey
KLOLZALDXGTNQE-JIDHJSLPSA-N
Synonyms
gw-642444m, gw642444m, vilanterol (as trifenatate)

Therapeutic areas

RespiratoryCOPDAsthma

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Vilanterol Trifenatate?

9 organisations hold an active US FDA Type II Drug Master File or a CEP for Vilanterol Trifenatate: Cipla Limited (India), Farmabios S.p.A. (Italy), GLAXOSMITHKLINE LLC, INKE SA (Spain), Lupin Limited (India), MSN Laboratories Private Limited (India), Neuland Laboratories Limited (India) and SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD, and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Vilanterol Trifenatate Drug Master Files are active?

Cipla Limited (DMF 39385), Farmabios S.p.A. (DMF 44519), GLAXOSMITHKLINE LLC (DMF 25906), INKE SA (DMF 35498), Lupin Limited (DMF 36668), MSN Laboratories Private Limited (DMF 34083), Neuland Laboratories Limited (DMF 36450) and SHANDONG RISEN-SUN PHARMACEUTICAL CO LTD (DMF 44117) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Vilanterol Trifenatate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Vilanterol Trifenatate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.